Charles Brynelsen has bought stock on 2 days since May 2025
Director at Envoy Medical, Inc., and 1 other company
SEC CIK 0001712459 · Filings on SEC.gov ↗
Charles Brynelsen's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
5 filings since Mar 2019, newest first
About Charles Brynelsen
Charles (Chuck) R. Brynelsen, age 68, is Chairman of the Board and Independent Director at Envoy Medical, Inc. (Nasdaq: COCH), having joined the board in 2023.( He recently engaged in significant insider trading, including purchasing 1,000,000 Class A shares at $0.40 on February 12, 2026, increasing his direct holdings to 1,050,000 shares, along with prior buys such as 38,000 shares in May 2025.(
Brynelsen brings over four decades of medical device leadership, notably as President of Abbott Vascular (2017–2021), President of Medtronic Early Technologies (2015–2016), Global President of Covidien Early Technologies (2013–2015), and CEO of IntraPace (2005–2012).( He held various commercial, corporate, international, and general management roles at Medtronic from 1981–2005.( Currently, he serves as Venture Partner at SpringRock Ventures (since 2015) and has directed private firms like Alebra Technologies (since 2010) and Neuspera Medical (2022–2023).( Brynelsen earned a BA from Bradley University and an MBA from Northwestern's Kellogg School of Management.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.